Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional triamcinolone for radiation-induced esophageal strictures
2012-001502-26Phase 2Terminated
- Sponsor
- IPO Lisboa
- Start
- May 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Esophageal stricture and radiation esophagitis comparing Triamcinolone intralesional injection with Placebo intralesional injection (2 arms). Primary endpoint: Number of esophageal dilations over 12 months. Started May 2012; status: terminated.
02
Drugs
triamcinolone
03
Conditions
Esophageal strictureradiation esophagitis
Beyond the preview
Go deeper on 2012-001502-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001502-26.